Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute corona...
Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims/Introduction
The cardiovascular (CV) outcomes of vildagliptin – a dipeptidyl peptidase‐4 inhibitor – in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke are unclear.
Materials and Methods
We analyzed data from the Taiwan National Health Insurance Research Database on 3,750 type 2 diabetes m...
Alternative Titles
Full title
Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a9d888cd9b7447ecabe48343270cba61
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a9d888cd9b7447ecabe48343270cba61
Other Identifiers
ISSN
2040-1116
E-ISSN
2040-1124
DOI
10.1111/jdi.13078
